Literature DB >> 9097023

Mouse CD-RAP/MIA gene: structure, chromosomal localization, and expression in cartilage and chondrosarcoma.

A K Bosserhoff1, S Kondo, M Moser, U H Dietz, N G Copeland, D J Gilbert, N A Jenkins, R Buettner, L J Sandell.   

Abstract

A cDNA encoding a novel protein has been previously isolated from two independent sources: melanoma cell cultures and chondrocytes. The protein from human melanoma cell lines and tumors is called melanoma inhibitory activity (MIA) (Blesch et al. [1994] Cancer Res. 54:5695-5701) and the protein from primary bovine chondrocytes and cartilaginous tissues is called cartilage-derived retinoic acid-sensitive protein (CD-RAP) (Dietz and Sandell [1996] J. Biol. Chem. 271:3311-3316). In order to investigate the gene regulation and function of CD-RAP/MIA, the mouse gene locus was isolated and analyzed. Developmental expression was determined by in situ hybridization to mouse embryos. Expression was limited to cartilaginous tissues and was initiated with the advent of chondrogenesis, remaining abundant throughout development. The mouse gene was isolated and sequenced from a 129Sv library and sequenced directly from an additional strain, B6C3Fe. The mouse CD-RAP/MIA gene is 1.5 kbp and consists of four exons. The promoter sequence of the gene contains many potential regulatory domains including 8 basic helix-loop-helix protein-binding domains and an AT-rich domain, both motifs shown to be present in the cartilage-specific enhancer of the type II procollagen gene. Other potential cis-acting motifs include binding sites for GATA-1, NF-IL6, PEA3, w-elements, NF kappa B, Zeste and Sp1. The gene, called cdrap, was localized to the end of an arm of chromosome 7 at the same site as the transforming growth factor beta 1 (Tgf-beta 1) and the glucose phosphate isomerase 1 (Gpi 1) genes. Potential mouse mutants that mapped to the same region of chromosome 7 were identified. Two of the potential mutants with skeletal phenotypes were sequenced, pudgy (pu) and extra toes with spotting (XsJ); however, no mutations were found in the coding sequence. To determine whether CD-RAP/MIA is associated with tumors of cartilage, mRNAs from a variety of rodent tissues and cell lines were screened. Expression was detected in a rodent tumor, the Swarm rat chondrosarcoma and a chondrosarcoma cell line derived from it, but not in other tissues or tumors of non-cartilage origin. Immunolocalization revealed CD-RAP/MIA protein localized in cartilage only. These results show that the normal expression of CD-RAP/MIA is limited to cartilage; however, pathologically, it is expressed both in melanoma and chondrosarcoma. The restricted expression of CD-RAP/MIA may provide an opportunity to monitor cartilage metabolic activity as well as the tumor activity of melanoma and chondrosarcoma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9097023     DOI: 10.1002/(SICI)1097-0177(199704)208:4<516::AID-AJA7>3.0.CO;2-L

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  21 in total

1.  Pitfalls in immunohistochemistry--a recent example.

Authors:  Alexander Riechers; Anja Katrin Bosserhoff
Journal:  Int J Clin Exp Pathol       Date:  2012-02-12

2.  Lentiviral arrays for live-cell dynamic monitoring of gene and pathway activity during stem cell differentiation.

Authors:  Roshan M Padmashali; Panagiotis Mistriotis; Mao-shih Liang; Stelios T Andreadis
Journal:  Mol Ther       Date:  2014-06-04       Impact factor: 11.454

3.  SOX10 promotes melanoma cell invasion by regulating melanoma inhibitory activity.

Authors:  Saskia A Graf; Christian Busch; Anja-Katrin Bosserhoff; Robert Besch; Carola Berking
Journal:  J Invest Dermatol       Date:  2014-03-07       Impact factor: 8.551

4.  Sequence-specific 1H, 13C, and 15N assignment of the human melanoma inhibitory activity (MIA) protein.

Authors:  R Stoll; C Renner; D Ambrosius; M Golob; W Voelter; R Buettner; A K Bosserhoff; T A Holak
Journal:  J Biomol NMR       Date:  2000-05       Impact factor: 2.835

5.  Solution structure and dynamics of melanoma inhibitory activity protein.

Authors:  Julie C Lougheed; Peter J Domaille; Tracy M Handel
Journal:  J Biomol NMR       Date:  2002-03       Impact factor: 2.835

6.  Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins.

Authors:  J C Lougheed; J M Holton; T Alber; J F Bazan; T M Handel
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

7.  Ultrastructural cartilage abnormalities in MIA/CD-RAP-deficient mice.

Authors:  Markus Moser; Anja-Katrin Bosserhoff; Ernst B Hunziker; Linda Sandell; Reinhard Fässler; Reinhard Buettner
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

8.  Misexpression of MIA disrupts lung morphogenesis and causes neonatal death.

Authors:  Sui Lin; Machiko Ikegami; Yan Xu; Anja-Katrin Bosserhoff; Alvin M Malkinson; John M Shannon
Journal:  Dev Biol       Date:  2008-02-15       Impact factor: 3.582

9.  Modulation of cartilage differentiation by melanoma inhibiting activity/cartilage-derived retinoic acid-sensitive protein (MIA/CD-RAP).

Authors:  Thomas Schubert; Jacqueline Schlegel; Rainer Schmid; Alfred Opolka; Susanne Grassel; Martin Humphries; Anja-Katrin Bosserhoff
Journal:  Exp Mol Med       Date:  2010-03-31       Impact factor: 8.718

10.  Reduced TFAP2A function causes variable optic fissure closure and retinal defects and sensitizes eye development to mutations in other morphogenetic regulators.

Authors:  Gaia Gestri; Robert J Osborne; Alexander W Wyatt; Dianne Gerrelli; Susan Gribble; Helen Stewart; Alan Fryer; David J Bunyan; Katrina Prescott; J Richard O Collin; Tomas Fitzgerald; David Robinson; Nigel P Carter; Stephen W Wilson; Nicola K Ragge
Journal:  Hum Genet       Date:  2009-12       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.